Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
302 studies found for:    "cyclic neutropenia" OR "Neutropenia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated
Has Results
Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Intervention: Biological: Filgrastim
2 Completed GCPGC in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Biological: GCPGC 3.6mg;   Biological: GCPGC 6mg;   Biological: Neulasta (pegfilgrastim) 6mg
3 Recruiting Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Condition: Neutropenia
Interventions: Drug: pegfilgrastim,30mcg/kg;   Drug: pegfilgrastim, 60mcg/kg;   Drug: pegfilgrastim, 100mcg/kg;   Drug: filgrastim, 5mcg/kg
4 Completed
Has Results
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Condition: Febrile Neutropenia
Intervention:
5 Completed Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Condition: Neutropenia
Interventions: Drug: HM10460A (45 μg/kg);   Drug: HM10460A (135 μg/kg);   Drug: HM10460A (270 μg/kg);   Drug: Pegfilgrastim 6mg
6 Completed Screening for Genes in Patients With Congenital Neutropenia
Condition: Congenital Neutropenia
Intervention: Genetic: High-throughput exome sequencing
7 Terminated Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Intervention: Drug: Ezatiostat Hydrochloride
8 Completed Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Empirical antimicrobial treatment discontinuation;   Other: Standard empirical antimicrobial treatment discontinuation
9 Completed A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
Condition: Neutropenia
Intervention:
10 Terminated
Has Results
Daptomycin Versus Placebo in Patients With Neutropenia and Fever
Condition: Febrile Neutropenia
Interventions: Drug: Daptomycin;   Other: Saline Placebo
11 Withdrawn Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Early antibiotic discontinuation;   Other: Usual practice
12 Recruiting Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
Condition: Febrile Neutropenia
Intervention:
13 Completed
Has Results
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
Condition: Febrile Neutropenia
Intervention: Drug: Antibacterial agent for the treatment of febrile neutropenia
14 Not yet recruiting ANF-Rho in the Treatment of Chronic Neutropenia
Condition: Neutropenia, Severe Chronic
Intervention: Drug: ANF-Rho
15 Completed Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Drug: PEG-G-CSF;   Drug: G-CSF
16 Completed Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Drug: PEG-G-CSF;   Drug: G-CSF
17 Recruiting Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
Condition: Chemotherapy-Induced Neutropenia
Intervention: Biological: Nivestim®
18 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
19 Completed
Has Results
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Condition: Chemotherapy-induced Neutropenia
Interventions: Biological: empegfilrastim;   Biological: filgrastim
20 Completed
Has Results
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Condition: Chemotherapy-induced Neutropenia
Interventions: Biological: Empegfilrastim 6 mg;   Biological: Filgrastim;   Biological: Placebo №1;   Biological: Placebo №2;   Biological: Empegfilrastim 7.5 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.